Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Leash raises cash for AI-driven medchem

by Michael McCoy
April 18, 2024 | A version of this story appeared in Volume 102, Issue 12

 

Leash Bio has raised $9.3 million in seed funding to develop a machine learning model of medicinal chemistry. The company, based in Salt Lake City, was founded by former employees of Recursion, which is combining artificial intelligence (AI) and experimentation in an attempt to industrialize biotechnology. Leash says it wants to accurately predict small-molecule drug candidates for any protein and, more broadly, interactions between any protein and any chemical.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.